Tag: Drug therapy

Clinical applications of preservative-free intraocular pressure-lowering drugs: the future prospects

Authors: Huang Jingjing,  Ge Jian DOI: 10.3760/cma.j.cn115989-20230419-00141 Published 2023-12-10 Cite as Chin J Exp Ophthalmol, 2023, 41(12): 1231-1236. Abstract                              [Download PDF] [Read Full Text] Long-term use of topical intraocular pressure-lowering medications, particularly those containing preservatives, may cause or worsen ocular surface diseases, […]

Progress in the treatment of thyroid-associated ophthalmopathy with teprotumumab

Authors: Liang Congbi,  Chen Changzheng DOI: 10.3760/cma.j.cn115989-20220526-00249 Published 2023-11-10 Cite as Chin J Exp Ophthalmol, 2023, 41(11): 1140-1144. Abstract                             【Download PDF】 【Read Full Text】 Thyroid-associated ophthalmopathy (TAO) is an autoimmune disease of complex etiology and pathogenesis, which can cause a variety of ocular […]

Advances in drug therapy of meibomian gland dysfunction

Authors: Li Yingli,  Liu Zuguo DOI: 10.3760/cma.j.cn115989-20211202-00668 Published 2023-05-10 Cite as Chin J Exp Ophthalmol, 2023, 41(5): 493-498. Abstract                              [Download PDF] [Read Full Text] Meibomian gland dysfunction (MGD) is a chronic, diffuse meibomian gland disorder, which has complex pathogenesis and high prevalence.It […]

Therapeutic effect of anti-IL-12/IL-23 p40 on experimental autoimmune uveitis and its mechanism

·Experimental Research· Therapeutic effect of anti-IL-12/IL-23 p40 on experimental autoimmune uveitis and associated mechanism Cui Xuexue, Zhang Zhihui, Wu Lingzi, Li Yongtao, Chen Shuang, Chen Nu, Zhang Xiaomin Tianjin Key Laboratory of Retinal Functions and Diseases, Tianjin Branch of National Clinical Research Center for Ocular Disease, Eye Institute and School of Optometry, Tianjin Medical University […]